Menin-MLL
Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.
Products for Menin-MLL
- Cat.No. Nombre del producto Información
-
GC11837
MI-136
MI-136 es un inhibidor de la interacciÓn proteÍna-proteÍna (PPI) menina-MLL, con una IC50 de 31 nM y una Kd de 23,6 nM. MI-136 muestra que bloquea la seÑalizaciÓn de AR y tiene el potencial para el estudio en tumores resistentes a la castraciÓn.
-
GC11418
MI-2
Menin-MLL inhibitor 2;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-propyl-
An inhibitor of menin-MLL fusion protein interactions -
GC10388
MI-2 (hydrochloride)
menin-MLL interaction inhibitor
-
GC12199
MI-3
Menin-MLL inhibitor 3;Thieno[2,3-d]pyrimidine, 4-[4-(4,5-dihydro-5,5-dimethyl-2-thiazolyl)-1-piperazinyl]-6-(1-methylethyl)-
An inhibitor of menin-MLL fusion protein interactions -
GC12173
MI-nc (hydrochloride)
weak inhibitor of menin-MLL interaction